Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Other financing activities (2020 - 2023)

Historic Other financing activities for Cullinan Therapeutics (CGEM) over the last 4 years, with Q4 2023 value amounting to $7.5 million.

  • Cullinan Therapeutics' Other financing activities fell 7194.82% to $7.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $30.4 million, marking a year-over-year decrease of 3557.82%. This contributed to the annual value of $37.8 million for FY2024, which is 2426.57% up from last year.
  • According to the latest figures from Q4 2023, Cullinan Therapeutics' Other financing activities is $7.5 million, which was down 7194.82% from $7.7 million recorded in Q3 2023.
  • Cullinan Therapeutics' Other financing activities' 5-year high stood at $26.8 million during Q4 2022, with a 5-year trough of $3.5 million in Q1 2021.
  • Over the past 4 years, Cullinan Therapeutics' median Other financing activities value was $7.5 million (recorded in 2023), while the average stood at $9.6 million.
  • As far as peak fluctuations go, Cullinan Therapeutics' Other financing activities skyrocketed by 10667.47% in 2022, and later crashed by 7194.82% in 2023.
  • Over the past 4 years, Cullinan Therapeutics' Other financing activities (Quarter) stood at $13.7 million in 2020, then soared by 58.25% to $21.7 million in 2021, then rose by 23.59% to $26.8 million in 2022, then tumbled by 71.95% to $7.5 million in 2023.
  • Its Other financing activities stands at $7.5 million for Q4 2023, versus $7.7 million for Q3 2023 and $7.9 million for Q2 2023.